Dr. Coleman Discusses the Toxicities Associated With Rucaparib in Patients With Ovarian Cancer
August 18th 2015Robert L. Coleman, MD, professor, Ann Rife Cox Chair in Gynecology, Department of Gynecologic Oncology and Reproductive Medicine, vice chair, Clinical Research, The University of Texas MD Anderson Cancer Center, discusses the toxicities associated with rucaparib in patients with ovarian cancer.
Watch
ELOQUENT-2 Study in Patients With Relapsed/Refractory Multiple Myeloma
August 17th 2015Sagar Lonial, MD, professor, School of Medicine, executive vice chair, Department of Hematology & Medical Oncology, chief medical officer, Winship Cancer Institute, Emory University, discusses the ELOQUENT-2 study in patients with relapsed/refractory multiple myeloma.
Watch
Toxicities Associated With Lenalidomide for Multiple Myeloma
August 14th 2015Philip McCarthy, MD, professor of oncology, director, Blood and Marrow Transplant Center, Department of Medicine, Roswell Park Cancer Institute, discusses the toxicities associated with lenalidomide for multiple myeloma in the CALGB 100104 study.
Watch
Lenalidomide vs. Placebo for Multiple Myeloma Patients Following a Single ASCT
August 13th 2015Sarah Holstein, MD, PhD, assistant professor of oncology, Roswell Park Cancer Institute, discusses a randomized study that compared lenalidomide with placebo for patients with multiple myeloma, following a single autologous stem cell transplant (ASCT).
Watch